Comments
Loading...

Inozyme Pharma

INZYNASDAQ
Logo brought to you by Benzinga Data
$2.98
0.020.68%
At close: -
$3.06
0.082.68%
After Hours: 7:10 PM EDT

Inozyme Pharma (NASDAQ:INZY) Stock Quotes, Forecast and News Summary

Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Jul
3
Aug
2
Sep
2
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$3.14
Close$2.98
Volume / Avg.1.45M / 418.12K
Day Range$2.95 - $3.46
52 Wk Range2.38 - 7.80
Market Cap$205.32M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
5.47%
Days to Cover5.43

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INZY
MGNX

FAQ

Q

How do I buy Inozyme Pharma (INZY) stock?

A

You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inozyme Pharma (INZY) competitors?

Q

What is the forecast, or price target, for Inozyme Pharma (INZY) stock?

A

Inozyme Pharma has a consensus price target of $14.88.

Q

What is the current price for Inozyme Pharma (INZY)?

A

The stock price for Inozyme Pharma (NASDAQ: INZY) is $3.06 last updated December 12, 2024 at 7:10 PM EST.

Q

Does Inozyme Pharma (INZY) pay a dividend?

A

There are no upcoming dividends for Inozyme Pharma.

Q

When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?

A

Inozyme Pharma’s Q4 earnings are confirmed for Tuesday, March 11, 2025.

Q

Is Inozyme Pharma (INZY) going to split?

A

There is no upcoming split for Inozyme Pharma.

Q

What sector and industry does Inozyme Pharma (INZY) operate in?

A

Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch